DMG-PEG2000-NH2: NH2-PEG Derivative for Lipid Nanoparticle Formulation

Executive Summary: DMG-PEG2000-NH2 is a primary amine-functionalized polyethylene glycol (PEG) derivative, widely used as a biocompatible linker in lipid nanoparticle (LNP) and liposomal drug delivery systems (APExBIO). Its molecular weight is 2528 Da, and it achieves solubility ≥51.6 mg/mL in DMSO, ≥52 mg/mL in ethanol, and ≥25.3 mg/mL in water under ambient conditions. The NH2 terminus enables efficient amide bond formation with carboxyl-containing biomolecules, supporting protein, peptide, and nucleic acid conjugation. DMG-PEG2000-NH2 enhances the stability, solubility, and biocompatibility of therapeutic payloads in LNPs and liposomes (Chen et al., 2021). The product is supplied by APExBIO at >90% purity with quality documentation.

Biological Rationale

PEG derivatives like DMG-PEG2000-NH2 are central to modern drug delivery due to their hydrophilicity and capacity to minimize immunogenicity (DMG-PEG2000-NH2: Mechanistic Advances). The primary amine group facilitates covalent conjugation to carboxylated biomolecules via amide bond formation, a process fundamental to bioconjugation and PEGylation workflows. This covalent linkage is highly stable under physiological conditions, making PEGylated complexes preferred for in vivo delivery. The 2000 Da PEG backbone offers an optimal balance between solubility enhancement and avoidance of rapid renal clearance (Benchmark NH2-PEG Derivative). Lipid-conjugated PEGs, such as DMG-PEG2000-NH2, are especially effective in LNP and liposomal formulations for delivering siRNA, small molecules, or proteins, as they stabilize the particle and prolong circulation half-life (APExBIO).

Mechanism of Action of DMG-PEG2000-NH2

DMG-PEG2000-NH2 consists of a dimyristoyl glycerol (DMG) lipid anchor, a 2 kDa polyethylene glycol spacer, and a terminal primary amine. The DMG moiety enables integration into lipid bilayers, anchoring the PEG chain at the nanoparticle or liposome surface. The PEG2000 spacer imparts hydrophilicity, steric stabilization, and resistance to opsonization. The terminal –NH2 group provides a reactive site for amide bond formation with activated carboxyl groups, typically mediated by EDC/NHS or equivalent chemistry (Translational Advantage).

• Anchoring: DMG allows stable insertion into lipid bilayers at concentrations up to 10 mol% of total lipid content without disrupting membrane integrity.
• PEG Shielding: The PEG segment (~2 kDa) forms a hydration shell, reducing protein adsorption and immune recognition.
• Conjugation: The –NH2 group reacts with –COOH under mild aqueous conditions (pH 6.5–8.0), yielding a stable amide linkage.
• Payload Versatility: Enables conjugation of peptides, proteins, antibodies, or nucleic acids with free carboxyl groups.

Evidence & Benchmarks

• DMG-PEG2000-NH2 achieves ≥90% purity by HPLC with CoA and MSDS available (APExBIO).
• Demonstrates solubility ≥51.6 mg/mL in DMSO, ≥52 mg/mL in ethanol, and ≥25.3 mg/mL in water at 20–25°C (APExBIO).
• Stable amide bond formation achieved under EDC/NHS activation at pH 7.2, 2 hours, 25°C; coupling efficiency >85% for model peptides (Benchmark NH2-PEG Derivative).
• In LNP formulations with 2–5 mol% DMG-PEG2000-NH2, siRNA encapsulation efficiency exceeds 90% using microfluidic mixing (Mechanistic Advances).
• PEGylation with DMG-PEG2000-NH2 prolongs nanoparticle circulation half-life 3–7x in mouse models relative to non-PEGylated controls (Chen et al., 2021).
• No detectable cytotoxicity at ≤100 μM in cell viability assays (24 h, HeLa cells, n=3) (Scenario-Driven Applications).

Applications, Limits & Misconceptions

DMG-PEG2000-NH2 is validated for:

• Lipid nanoparticle (LNP) formulation for siRNA, mRNA, or small-molecule delivery (Translational Advantage).
• Liposomal drug delivery for hydrophobic and hydrophilic payloads.
• Bioconjugation reagent for amide bond formation between proteins/peptides and carboxylated surfaces.
• Enhancing solubility/biocompatibility of conjugated biomolecules (APExBIO).
• Cell-based assay enhancement by reducing non-specific binding and aggregation (Enhancing Cell-Based Assays).

For a detailed contrast, "DMG-PEG2000-NH2: Mechanistic Advances" focuses on molecular utility and translational impact, while this article provides an up-to-date, parameterized reference with evidence-backed benchmarks.

Common Pitfalls or Misconceptions

• Not compatible with non-amine conjugation: DMG-PEG2000-NH2 only reacts with carboxyl groups, not with aldehydes or thiols.
• Limited stability in solution: Aqueous or organic solutions should not be stored long-term; prepare fresh for each use (store solid at –20°C).
• Ineffective without activation chemistry: Amide bond formation requires EDC/NHS or equivalent activation; direct mixing is insufficient.
• PEG length is not universal: The 2 kDa PEG may not provide optimal stealth or circulation for all payloads; empirical optimization may be needed.
• Not suitable for targeted delivery without further modification: Lacks inherent targeting ligands—further functionalization is required for active targeting.

Workflow Integration & Parameters

DMG-PEG2000-NH2 integrates seamlessly into standard LNP and liposome assembly protocols. For LNPs, it is typically mixed at 2–5 mol% with core lipids (e.g., DSPC, cholesterol, ionizable lipid) before rapid mixing via microfluidics. For amide coupling, dissolve DMG-PEG2000-NH2 in DMSO or ethanol at ≥50 mg/mL, combine with activated carboxyl partner in phosphate buffer (pH 7.2–7.5), and incubate at 25°C for 1–2 hours. Remove unreacted linker by dialysis or size exclusion chromatography. Store solid at –20°C and avoid repeated freeze-thaw cycles. Quality documentation (CoA, MSDS) is supplied by APExBIO.

For further protocol details and scenario-driven optimization, see the Scenario-Driven Applications article, which provides laboratory troubleshooting and protocol validation; this current article extends those findings with additional quantitative benchmarks and parameter ranges.

Conclusion & Outlook

DMG-PEG2000-NH2 (SKU M2006) is a validated, high-purity NH2-PEG derivative optimized for robust amide bond formation, LNP/liposomal formulation, and bioconjugation. It improves nanoparticle stability, solubility, and circulation time, supporting the development of advanced nucleic acid and protein therapeutics. While not inherently targeted or suitable for non-amine chemistries, it remains a cornerstone reagent for PEGylation and biocompatible linker strategies. For ordering, technical details, and documentation, visit the official DMG-PEG2000-NH2 product page.